BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Lanx Launches Durango(TM) Stand-Alone ALIF System


4/12/2011 7:02:40 AM

BROOMFIELD, Colo., April 12, 2011 /PRNewswire/ -- Lanx®, Inc., a privately held medical device company focused on developing and commercializing innovative devices for spinal surgery, today announced the initial launch of its Durango Stand-Alone ALIF System (Durango), following 510(k) clearance in February. The announcement was made at the 2011 American Association of Neurological Surgeons (AANS) Annual Meeting, Denver, CO.

The Durango system is intended to treat degenerative disc disease at one or two levels from L2 to S1 through anterior lumbar interbody fusion (ALIF), and has been approved as a stand-alone implant when used with all four fixation screws. It is the first system on the market to offer multiple plate options, including a full plate, a zero-profile plate, and the first ever half plate with 15 degree angled screws for more challenging anatomies.

"The Durango system expands the breadth of our fusion portfolio, offering a reliable, integrated ALIF solution to meet the needs and preferences of surgeons and improve care for diverse patient anatomies," said Dan Gladney, Chief Executive Officer, Lanx. "After several successful cases, the new anchored cage continues to receive positive feedback regarding the versatility of its plate options and the system's ease of implantation."

The Durango system has been designed to improve stability and promote fusion, combining a PEEK OPTIMA® LT1 large footprint interbody spacer, a titanium anterior plate and four fixation screws. The system also includes a full set of specialized instrumentation and a one-step cover plate with a secure, center set screw to prevent screw back-out.

"The thoughtful design of the Durango system, with its variety of plates and screw angles, is significant in that it allows for a unique, tailored approach to ALIF based on the affected vertebral level and patient's anatomy," said Randall W. Porter, M.D., neurosurgeon at Barrow Neurosurgical Associates in Phoenix, AZ, and one of the first surgeons to use Durango. "The new half plate option with its reduced screw angle is especially advantageous for difficult cases in the L5 to S1 region of the spine. Even the system's low profile full plate limits concern for distortion of overlying vessels."

Broadening the Lanx ALIF portfolio, the new anchored cage is expected to be fully commercialized in the U.S. by Q4 2011, joining the recently-launched Epic Anterior Thoracolumbar Plating System and the Breckenridge Interbody/VBR Fusion System.

The Durango system is one of several innovative products that will be on display at the Lanx AANS booth #1016. For more information about the Durango system or Lanx, please visit www.lanx.com.

About Lanx, Inc.

Lanx is one of the largest and fastest growing privately held global spine companies. The Company was founded by a team of experienced medical device professionals and engineers in 2003 to improve the quality of spine care and provide surgeons with innovative products. Lanx develops and markets a full line of fusion technologies with a focus on minimally invasive and biologics products. The Company is headquartered in Broomfield, CO. More information on Lanx and its spinal surgery products can be found at www.lanx.com.

Company Contact:

Media / Investors:

Steve Deitsch

Kim Muscara / Nick Laudico

Chief Financial Officer

(646) 536-7011/ 7030

(303) 443-7500

kmuscara@theruthgroup.com

steve.deitsch@lanx.com

nlaudico@theruthgroup.com



SOURCE Lanx, Inc.


Read at BioSpace.com

Lanx
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->